Phoenix Biotech Acquisition Corp. - Class A
News
CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics
Business Wire CERo Therapeutics, Inc. (CERo), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (PBAX), a special purpose acquisition company formed for the purpose of...\n more…
Mint Tower Capital Management B.V. Purchases New Holdings in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)
Ticker Report Mint Tower Capital Management B.V. purchased a new stake in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX Get Rating) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 80,...\n more…
Parallax Volatility Advisers L.P. Makes New $340,000 Investment in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)
Zolmax Parallax Volatility Advisers L.P. acquired a new position in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,721 shares of the ...\n more…
Marshall Wace LLP Increases Holdings in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)
Ticker Report Marshall Wace LLP boosted its stake in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX Get Rating) by 33.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 849,472 shares of the ...\n more…
OLD Mission Capital LLC Takes $106,000 Position in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)
Zolmax OLD Mission Capital LLC purchased a new stake in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX Get Rating) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 10,456 shares of the companys stock, valued at approximately $106,000...\n more…
Glazer Capital LLC Purchases New Shares in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)
Zolmax Glazer Capital LLC purchased a new stake in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX Get Rating) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,221 shares of the companys stock, valued at approximately $103,000. ...\n more…